Impact of enhanced compliance initiatives on the efficacy of rosuvastatin in reducing low density lipoprotein cholesterol levels in patients with primary hypercholesterolaemia

R Dariolo

doi:10.4414/smw.2008.12120

Original article

Vol. 138 No. 2930 (2008)

Impact of enhanced compliance initiatives on the efficacy of rosuvastatin in reducing low density lipoprotein cholesterol levels in patients with primary hypercholesterolaemia

R Dariolo

Fulltext PDF

DOI: https://doi.org/10.4414/smw.2008.12120
Cite this as:: Swiss Med Wkly. 2008;138:420-426
Published: 26.07.2008

How to Cite

1.

Dariolo R. Impact of enhanced compliance initiatives on the efficacy of rosuvastatin in reducing low density lipoprotein cholesterol levels in patients with primary hypercholesterolaemia. Swiss Med Wkly [Internet]. 2008 Jul. 26 [cited 2024 Apr. 23];138(2930):420-6. Available from: https://smw.ch/index.php/smw/article/view/876

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.